SynthesisFrontiers in immunology2024

Impact of programmed cell death protein 1 inhibitor therapy on the survival of patients with advanced or recurrent uterine cancers: a meta-analysis.

Keng-Wei Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.